Revel Pharmaceuticals Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4M

  • Investors
  • 10

Revel Pharmaceuticals General Information

Description

Developer of therapeutic enzymes designed for degrading molecular damage associated with aging. The company's platform integrates enzyme discovery and engineering capabilities, encompassing design, optimization, and production of repair based catalytic treatments that clear toxic metabolites and protein modifications, enabling healthcare providers and researchers to target a range of age related diseases such as osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes with molecular level repair.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2325 3rd Street
  • Room 214
  • San Francisco, CA 94107
  • United States
+1 (217)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 2325 3rd Street
  • Room 214
  • San Francisco, CA 94107
  • United States
+1 (217)

Revel Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Revel Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 30-Sep-2025 $4M Completed Generating Revenue
7. Grant 01-May-2024 Completed Generating Revenue
6. Grant 01-Aug-2023 Completed Generating Revenue
5. Early Stage VC 17-Mar-2022 Completed Generating Revenue
4. Early Stage VC 07-Apr-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Jan-2021 Cancelled Generating Revenue
2. Seed Round 07-Jan-2020 $1.5M $1.5M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Revel Pharmaceuticals’s complete valuation and funding history, request access »

Revel Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
Seed 3,555,472 $0.000010 $0.3 $0.3 1x $0.3 6.42%
To view Revel Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Revel Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revel Pharmaceuticals Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gaingels Venture Capital Minority
Hyperspeed Ventures Venture Capital Minority
LongGame Ventures Venture Capital Minority
U.S. Department of Health and Human Services Government
Formic Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Revel Pharmaceuticals FAQs

  • When was Revel Pharmaceuticals founded?

    Revel Pharmaceuticals was founded in 2020.

  • Where is Revel Pharmaceuticals headquartered?

    Revel Pharmaceuticals is headquartered in San Francisco, CA.

  • What is the size of Revel Pharmaceuticals?

    Revel Pharmaceuticals has 8 total employees.

  • What industry is Revel Pharmaceuticals in?

    Revel Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Revel Pharmaceuticals a private or public company?

    Revel Pharmaceuticals is a Private company.

  • What is Revel Pharmaceuticals’s current revenue?

    The current revenue for Revel Pharmaceuticals is .

  • How much funding has Revel Pharmaceuticals raised over time?

    Revel Pharmaceuticals has raised $14.7M.

  • Who are Revel Pharmaceuticals’s investors?

    Gaingels, Hyperspeed Ventures, LongGame Ventures, U.S. Department of Health and Human Services, and Formic Ventures are 5 of 10 investors who have invested in Revel Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process